The new guidelines include three strong recommendations: Universal treatment with hydroxychloroquine (absent ...

The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology (ACR) Convergence 2025 meeting in ...

Large language models, when used alongside human clinical judgement, “substantially” improved diagnostic accuracy among a ...

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced it will be presenting a ...

Results from the trial's first year were reported at the 2024 ACR meeting, and they persuaded the FDA to approve the drug for ...

Even for a newly minted Nobel laureate, downtime is hard to find. | Even for a newly minted Nobel laureate, downtime is hard ...

Healthcare providers are invited to attend a rural health outreach Rheumatology Conference focused on lupus, taking place Friday, July 18, at noon in the Team-Based Learning Center at the Alabama ...

Palleon Pharmaceuticals, a company developing sialoglycan degradation as a therapy to treat autoimmune diseases and cancer, today announced two upcoming poster presentations at key autoimmune disease ...

CreakyJoints®, the leading multi-language global digital community for people with chronic arthritis, and part of the Global Healthy Living Foundation (GHLF), was the top social media organization at ...